Aucatzyl, a therapy to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia has received FDA approval. Aucatzyl joins Gilead’s Tecartus and Novartis’ Kymriah. Autolus has wrapped up all pre-launch activities and will now move to finish the final steps involved in onboarding treatment centers.

Johnson & Johnson and Legend Biotech’s Carvykti showed it could prevent disease progression in the earlier treatment of multiple myeloma, now results are showing that a single dose slashed the death risk by 45% compared with two traditional combination treatments in myeloma patients who had received at least one prior line of therapy, according to an update of the phase 3 CARTITUDE-4 trial.

Paiji Yoo, CEO and co-founder of Blueland says, “I like to lead as an open and collaborative leader. And I think that is a must-have for every team member that we bring on.”

The FDA has cleared Apple's new sleep apnea detection feature for use. It will be available on Apple Watch Series 9, Series 10 and Ultra 2 later this month.

FiercePharma is shining a spotlight on the people and companies who are driving meaningful change in healthcare, pharma and biotech. This is the second edition of the Fierce 50, and honors a steadfast dedication and the vision that push these industries forward.

Chances are you have heard this question during an interview, “Tell me about yourself.” While most interviewers use this as an opener to an interview, answering it with a breakdown of your whole history could be a mistake. Think about using this time to make a strong first impression.

With the approval of Livdelzi, Gilead Sciences is growing its liver disease portfolio. Livdelzi is used to treat primary biliary cholangitis (PBC), a rare liver disease that occurs when your body’s immune system incorrectly attacks your bile ducts.

We know many of you are struggling with being downsized and others are frustrated with the interview process and lack of feedback from companies. A friend shared this inspiring article and we are passing it on. Times will change, they always do!

The FDA has approved Ascendis’ Yorvipath, a hormone replacement therapy to treat hypoparathyroidism. Ascendis was ready to bring the drug to the market 15 months ago but was rejected due to a manufacturing problem. Then 3 months ago things were delayed when the FDA said they needed additional time to make its decision. Initial supplies should be available in the first quarter of 2025.

A 2022 recall stopped the launch of Roche's eye implant, Susvimo, due to manufacturing concerns. This is good news for patients with wet age-related macular degeneration (AMD) as Susvimo is a refillable eye implant that only requires two refills per year offering an alternative to standard-of-care eye injections to treat the disease.

It’s always important to have some questions prepared for your interview. According to Andrew McCaskill, a LinkedIn career expert, there is one question you should always ask.

Here’s an interesting article on how to use the ‘golden question’ to manage your emotions, make better decisions, and live life with fewer regrets. What is the golden question? It is actually 5 questions…

Verona Pharma plc has announced the FDA approval of Ohtuvayre. This is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years.

Here’s a look at the 10 highest paid CEOs of 2023. Leading the pack with a 116% increase over his 2022 salary is Johnson & Johnson’s CEO, Joaquin Duato.

According to Jeremy Schifeling, a hiring manager and cofounder of a career development business, many job seekers were using these generative AI tools the wrong way thus creating massively generic resumes.

This is the final part of a three-part series examining the latest advancements in cell and gene therapy manufacturing.

Patent expirations and the rise of weight loss medications led to some surprises in the top 20 drugs by global sales. With more than 30 indications across various cancer types and stages, Merck’s Keytruda was top of the list last year. With $25 billion in global sales, the drug accounted for about 40% of Merck’s total

According to new research from ADP, “a strong work ethic” is the top skill companies are looking for in a new hire. Individuals who possess it are characteristically punctual, organized, efficient with their time, and most importantly, willing to go the extra mile to get the job done well.

As patients increasingly steer their own health journeys, pharma marketers have an opportunity to make an impact through health education that drives informed and proactive decision-making. They can do this by answering critical questions, anticipating needs and guiding the patient as they move forward, and open gateways to comprehensive support.

Artificial intelligence (AI) is a hot topic in business, amongst companies and their consumers alike. While the implementation of the technology has been met with uncertainty at times, it seems to have significantly boosted job satisfaction levels for customer service personnel – and in turn, improved the overall customer experience for consumers.

If you are in the process of updating your resume, consider replacing these words with stronger words.

Managed - use - Directed
Responsible for - use - Oversaw
Did - use - Accomplished
Helped - use - Crafted

According to Babbel’s survey of 2,000 US office workers, 88% of people have regretted a work email right after hitting send. According to Esteban Touma, a Cultural and Linguistics expert at Babbel, two big mistakes that can lead to regret are having typos and unclear messaging in the email.

The only two companies to have double-digit sales increases by revenue in 2023 were Novo Nordisk’s Ozempic and Eli Lily’s Mounjaro, mostly due to the popularity of injected weight loss drugs. Their revenue increase was 31% and 20% respectively.

Interesting data from a recent ContactBabel survey of 1,000 customers regarding Audio Improvement & Noise Reduction for effective call center communication.

Congratulations to my stepdaughter Sara Nugent on her first AJMC publication!

Here’s an up-to-date guide from Quantexa that delves into how AI is transforming decision-making for business leaders, providing essential knowledge and practical strategies.

An interesting look at PitchBook's Data Analytics report outlining the trends and critical opportunities that will define the industry in years to come. 

Fierce Pharma’s initial field of 32 is down to the Sweet 16.

Eli Lilly’s diabetes med Mounjaro strolled to victory over Bristol Myers Squibb’s heart drug Camzyos by 72% to 28%.